Member-only story

Featured

Breakthrough in Bacterial Cancer Therapy

BacID Therapy - A Targeted Approach to Cancer Treatment

Josh Universe
Biohackers Media

--

A recent breakthrough in cancer treatment has emerged from a collaborative effort between the University of Massachusetts Amherst and Ernest Pharmaceuticals, culminating in developing a non-toxic bacterial therapy known as BacID. This innovative approach aims to deliver cancer-fighting drugs directly into tumors, enhancing treatment efficacy and minimizing the harsh side effects of traditional therapies like chemotherapy.

Overview of BacID Therapy

The BacID therapy is designed specifically for treating high-mortality cancers, including liver cancer, ovarian cancer, and metastatic breast cancer. The significant potential of BacID to revolutionize cancer care lies in its targeted mechanism that spares healthy tissue from damage while ensuring a high delivery concentration of therapeutic agents directly to tumor cells.

According to Neil Forbes, the senior author of the study published in Molecular Therapy, the therapy represents a critical advancement in treating late-stage cancers. “What we’re trying to do is unlock the potential to treat late-stage cancers,” he stated, highlighting the inherent properties of bacteria that naturally home to tumors.

Mechanism of Action

--

--

No responses yet